Starten Sie Ihre Suche...


Durch die Nutzung unserer Webseite erklären Sie sich damit einverstanden, dass wir Cookies verwenden. Weitere Informationen

SFB 432: Mechanismen der Tumorabwehr und ihre therapeutische Beeinflussung

Forschungsverbund / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10

Holtappels, R; Simon, CO; Munks, MW et al.

Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination.

J Virol. Bd. 82. H. 12. 2008 S. 5781-96


Hahnel, PS; Thaler, S; Antunes, E et al.

Targeting AKT signaling sensitizes cancer to cellular immunotherapy.

Cancer Res. Bd. 68. H. 10. 2008 S. 3899-906




Koslowski, M; Sahin, U; Mitnacht-Kraus, R et al.

A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes.

Cancer Res. Bd. 67. H. 19. 2007 S. 9528-34


Roos, WP; Batista, LFZ; Naumann, S et al.

Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine

Oncogene. Bd. 26. 2007 S. 186-197


Kuball, J; Dossett, ML; Wolfl, M et al.

Facilitating matched pairing and expression of TCR chains introduced into human T cells.

Blood. Bd. 109. H. 6. 2007 S. 2331-8



Tuettenberg, A; Koelsch, S; Knop, J et al.

Oxymetazoline modulates proinflammatory cytokines and the T-cell stimulatory capacity of dendritic cells.

Exp Dermatol. Bd. 16. 2007 S. 171-178


Besold, K; Frankenberg, N; Pepperl-Klindworth, S et al.

Processing and MHC class I presentation of human cytomegalovirus pp65-derived peptides persist despite gpUS2-11-mediated immune evasion

J Gen Virol. Bd. 88. 2007 S. 1429-1439